Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DFB (Shanghai) Medical Technology is a Sino-American joint venture founded in 2016 and headquartered in Shanghai. The company specializes in the development and manufacturing of high-level disinfection and sterilization solutions for the healthcare industry, with a primary focus on medical infection control. Its flagship product, Aldahol, is a patented high-level disinfectant that combines glutaraldehyde and isopropanol to provide rapid, room-temperature sterilization of surgical equipment and endoscopes. Operating as the Chinese arm of the US-based DFB Pharmaceuticals, the company maintains a world-class manufacturing facility in China that adheres to GMP standards to serve domestic medical institutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DFB (Shanghai) Medical Technology.